Product NDC: | 43066-360 |
Proprietary Name: | Nexterone |
Non Proprietary Name: | amiodarone hydrochloride |
Active Ingredient(s): | 360 mg/200mL & nbsp; amiodarone hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43066-360 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022325 |
Marketing Category: | NDA |
Start Marketing Date: | 20111212 |
Package NDC: | 43066-360-20 |
Package Description: | 200 mL in 1 BAG (43066-360-20) |
NDC Code | 43066-360-20 |
Proprietary Name | Nexterone |
Package Description | 200 mL in 1 BAG (43066-360-20) |
Product NDC | 43066-360 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | amiodarone hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111212 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | AMIODARONE HYDROCHLORIDE |
Strength Number | 360 |
Strength Unit | mg/200mL |
Pharmaceutical Classes | Antiarrhythmic [EPC] |